Cargando…
Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114547/ https://www.ncbi.nlm.nih.gov/pubmed/27841271 http://dx.doi.org/10.1038/ncomms13513 |
| _version_ | 1782468357673451520 |
|---|---|
| author | Chabon, Jacob J. Simmons, Andrew D. Lovejoy, Alexander F. Esfahani, Mohammad S. Newman, Aaron M. Haringsma, Henry J. Kurtz, David M. Stehr, Henning Scherer, Florian Karlovich, Chris A. Harding, Thomas C. Durkin, Kathleen A. Otterson, Gregory A. Thomas Purcell, W. Ross Camidge, D. Goldman, Jonathan W. Sequist, Lecia V. Piotrowska, Zofia Wakelee, Heather A. Neal, Joel W. Alizadeh, Ash A. Diehn, Maximilian |
| author_facet | Chabon, Jacob J. Simmons, Andrew D. Lovejoy, Alexander F. Esfahani, Mohammad S. Newman, Aaron M. Haringsma, Henry J. Kurtz, David M. Stehr, Henning Scherer, Florian Karlovich, Chris A. Harding, Thomas C. Durkin, Kathleen A. Otterson, Gregory A. Thomas Purcell, W. Ross Camidge, D. Goldman, Jonathan W. Sequist, Lecia V. Piotrowska, Zofia Wakelee, Heather A. Neal, Joel W. Alizadeh, Ash A. Diehn, Maximilian |
| author_sort | Chabon, Jacob J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5114547 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-51145472016-11-29 Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients Chabon, Jacob J. Simmons, Andrew D. Lovejoy, Alexander F. Esfahani, Mohammad S. Newman, Aaron M. Haringsma, Henry J. Kurtz, David M. Stehr, Henning Scherer, Florian Karlovich, Chris A. Harding, Thomas C. Durkin, Kathleen A. Otterson, Gregory A. Thomas Purcell, W. Ross Camidge, D. Goldman, Jonathan W. Sequist, Lecia V. Piotrowska, Zofia Wakelee, Heather A. Neal, Joel W. Alizadeh, Ash A. Diehn, Maximilian Nat Commun Corrigenda Nature Publishing Group 2016-11-14 /pmc/articles/PMC5114547/ /pubmed/27841271 http://dx.doi.org/10.1038/ncomms13513 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Corrigenda Chabon, Jacob J. Simmons, Andrew D. Lovejoy, Alexander F. Esfahani, Mohammad S. Newman, Aaron M. Haringsma, Henry J. Kurtz, David M. Stehr, Henning Scherer, Florian Karlovich, Chris A. Harding, Thomas C. Durkin, Kathleen A. Otterson, Gregory A. Thomas Purcell, W. Ross Camidge, D. Goldman, Jonathan W. Sequist, Lecia V. Piotrowska, Zofia Wakelee, Heather A. Neal, Joel W. Alizadeh, Ash A. Diehn, Maximilian Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients |
| title | Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients |
| title_full | Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients |
| title_fullStr | Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients |
| title_full_unstemmed | Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients |
| title_short | Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients |
| title_sort | corrigendum: circulating tumour dna profiling reveals heterogeneity of egfr inhibitor resistance mechanisms in lung cancer patients |
| topic | Corrigenda |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114547/ https://www.ncbi.nlm.nih.gov/pubmed/27841271 http://dx.doi.org/10.1038/ncomms13513 |
| work_keys_str_mv | AT chabonjacobj corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT simmonsandrewd corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT lovejoyalexanderf corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT esfahanimohammads corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT newmanaaronm corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT haringsmahenryj corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT kurtzdavidm corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT stehrhenning corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT schererflorian corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT karlovichchrisa corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT hardingthomasc corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT durkinkathleena corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT ottersongregorya corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT thomaspurcellw corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT rosscamidged corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT goldmanjonathanw corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT sequistleciav corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT piotrowskazofia corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT wakeleeheathera corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT nealjoelw corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT alizadehasha corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients AT diehnmaximilian corrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients |